Deep Intelligent Pharma: Funding, Investors & Team (Sep 2026)
Deep Intelligent Pharma (DIP) is a Singapore-based AI company that helps pharmaceutical and biotech companies run clinical trials faster, cheaper, and with fewer mistakes. Its AI platform automates many slow and manual tasks, such as writing trial documents, designing studies, analyzing data, translating medical content for global regulators, and preparing regulatory submissions. By using thousands of small AI agents supervised by experts, DIP not only saves time but also helps improve the chance that a clinical trial will succeed. Its technology has already been proven in real cases, including an AI-written protocol approved by Japan’s regulator with no revisions. Today, DIP works with over 1,000 life science companies worldwide, including major names like Bayer, Johnson & Johnson, and Roche.
Deep Intelligent Pharma has raised $100M across 2 funding rounds on record, the most recent an undisclosed round of $40.0M announced in Mar 2026.
That round is above the $5.5M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.
Deep Intelligent Pharma Company Profile and Key Stats
Latest funding round on record: Mar 2026.
Deep Intelligent Pharma Funding Rounds
Deep Intelligent Pharma raised $60.0M in a Series D announced in Feb 2026.
1 month later, an undisclosed round of $40.0M was announced in Mar 2026.
Deep Intelligent Pharma Founders and Leadership Team
Contact details for the Deep Intelligent Pharma team: 1 has a LinkedIn profile.
Start 14-day free trial →Deep Intelligent Pharma Funding Compared to Other Artificial Intelligence Startups
Deep Intelligent Pharma's latest round of $40.0M is above the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Deep Intelligent Pharma in Artificial Intelligence and Singapore
Companies Similar to Deep Intelligent Pharma
fileAI is the world's only horizontal file processing agent and AI workflow automation platform, addressing…
Strutt produces and supplies AI sensor vehicles and mobility products.
Ropedia focuses on creating a data infrastructure for spatial and physical intelligence.
Akro AI develops platforms that automate document-heavy data workflows. The company deploys a network of…
Acti is an "agentic" smartphone keyboard developed by TypeX Limited that turns any text field into an AI…
Alice is a omni-channel conversational AI based SAAS platform to Boost Sales, Automate Support and Reduce…
The goal of ChemT Biotechnology is to increase patient access to the most cutting-edge biologics, beginning…
H3 Zoom is an AI-powered inspection intelligence platform focused on the built environment, helping…
Synvo AI is building the multimodal memory layer of artificial intelligence—enabling machines to remember,…
GERO is an AI Drug Discovery company created to solve chronic diseases
Galaxy Data Center builds future-ready digital infrastructure that’s sustainable, efficient, reliable, and…
SiliconFlow is an artificial intelligence infrastructure company that develops cloud-based platforms and…
Deep Intelligent Pharma Funding FAQs
What does Deep Intelligent Pharma do?
Deep Intelligent Pharma (DIP) is a Singapore-based AI company that helps pharmaceutical and biotech companies run clinical trials faster, cheaper, and with fewer mistakes. Its AI platform automates many slow and manual tasks, such as writing trial documents, designing studies, analyzing data, translating medical content for global regulators, and preparing regulatory submissions. By using thousands of small AI agents supervised by experts, DIP not only saves time but also helps improve the chance that a clinical trial will succeed. Its technology has already been proven in real cases, including an AI-written protocol approved by Japan’s regulator with no revisions. Today, DIP works with over 1,000 life science companies worldwide, including major names like Bayer, Johnson & Johnson, and Roche.
How much funding has Deep Intelligent Pharma raised?
Deep Intelligent Pharma has raised $100M across 2 rounds on record. The most recent is an undisclosed round of $40.0M announced in Mar 2026.
When did Deep Intelligent Pharma last raise funding?
Deep Intelligent Pharma's most recent funding round on record is an undisclosed round of $40.0M, announced in Mar 2026.
Who founded Deep Intelligent Pharma?
FundedIQ lists Hygeia (xing) Li (Founder), Xing Li (Founder) at Deep Intelligent Pharma.
Where is Deep Intelligent Pharma headquartered?
Deep Intelligent Pharma is based in Singapore, Central Region, Singapore.
How many employees does Deep Intelligent Pharma have?
Deep Intelligent Pharma is in the 51-100 employee band.
How does Deep Intelligent Pharma's funding compare to other Artificial Intelligence startups?
Deep Intelligent Pharma's latest round of $40.0M is above the $5.5M median round size for Artificial Intelligence companies on FundedIQ across 7,233 tracked companies over the last two years.
About FundedIQ's Deep Intelligent Pharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Deep Intelligent Pharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.